摘要
目的:探讨布地奈德、特布他林雾化吸入治疗小儿喘息性支气管炎的疗效。方法:将江西省新余市人民医院在2017年5月至2018年5月收治60例喘息性支气管炎患儿,以奇偶分组法,分为实验组和参照组,每组均为(n=30)。实验组通过布地奈德+特布他林雾化吸入治疗,参照组通过地塞米松滴注治疗,对实验组和参照组的临床效果进行观察。结果:实验组、参照组的治疗总有效率分别为:93.33%、70%,前者明显高于后者,P<0.05。两组临床症状(发热、气急、咳嗽、肺部喘鸣音)消失时间比较,实验组均明显短于参照组,P<0.05。结论:小儿喘息性支气管炎治疗中,运用布地奈德+特布他林雾化吸入治疗,临床疗效确切,且能很好地改善患儿临床症状和体征,适用于小儿喘息性支气管炎治疗中应用和推广。
Objective To investigate the efficacy of budesonide and terbutaline aerosol inhalation in the treatment of asthmatic bronchitis in children. Methods： From May 2017 to May 2018, 60 children with asthmatic bronchitis were treated in our hospital. The experimental group was treated by budesonide terbutaline atomization inhalation and the control group by dexamethasone drip. The clinical effects of the experimental group and the reference group were observed. Results： In the experimental group, the total effective rate of the control group was 70% 93.33 and the former was significantly higher than that of the latter （P〈0.05）. The time of disappearance of clinical symptoms （fever, shortness of breath, cough, lung wheezing） in the two groups was significantly shorter than that in the control group （P〈0.05）. Conclusion： Budesonide terbutaline aerosol inhalation is effective in the treatment of asthmatic bronchitis in children and can improve the clinical symptoms and signs of children. It is suitable for the treatment of asthmatic bronchitis in children.
作者
蒋玲
刘小明
李志军
JIANG Ling;LIU Xiao-ming;LI Zhi-jun(Xinyu People＇s Hospital of Jiangxi Province,Xinyu Jiangxi 338000,China)
出处
《药品评价》
CAS
2018年第21期21-23,共3页
Drug Evaluation
基金
江西省卫生厅课题(编号:20157155)
关键词
布地奈德
特布他林
雾化吸入治疗
小儿喘息性支气管炎
临床疗效
Budesonide
Terbutaline
Nebulized Inhalation Therapy
Pediatric Asthmatic Bronchitis
Clinical Efficacy
